Today's Daily Dose brings you news about Acceleron Pharma's pulmonary arterial hypertension trial data; FDA approval of Lilly's combination tablet containing three type 2 diabetes medicines in one pill; Merck's DIFICID tablets and oral suspension securing the regulatory nod in the U.S. and miRagen's near-term catalyst.
from RTT - Biotech https://ift.tt/2O5s4BT
via IFTTT
No comments:
Post a Comment